Sun Pharmaceutical Industries Cash Flow Annual

BSE: 524715 | NSE: SUNPHARMA | ISIN: INE044A01036 | Sector: Biotechnology & Drugs
1,664.00 +16.65 (1.01%)Updated : 20 Jun 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Net Income/ Starting Line 13,752.1311,087.899,408.434,481.32
Depreciation/ Depletion 2,575.392,556.642,529.432,143.74
Non- Cash Items -1,455.03-1,002.24193.13-168.79
Changesin Working Capital -800.43-506.02-6,604.972,569.72
Cashfrom Operating Activities 14,072.0612,136.275,526.029,025.99
Capital Expenditures -2,128.58-2,201.81-2,085.58-1,495.04
Other Investing Cash Flow Items Total -3,177.581,511.61-5,858.10-4,229.70
Cashfrom Investing Activities -5,306.16-690.20-7,943.68-5,724.74
Financing Cash Flow Items -3,127.00-298.96-100.09-269.18
Total Cash Dividends Paid -3,613.97-2,898.17-2,518.88-2,158.92
Issuance( Retirement)of Debt Net -1,164.85-3,513.034,995.04-2,765.36
Cashfrom Financing Activities -7,905.82-6,710.162,376.07-5,193.46
Foreign Exchange Effects 123.04-73.99157.07127.43
Net Changein Cash 983.124,661.92115.48-1,764.78
Cash Interest Paid 223.82219.0399.2473.21
Cash Taxes Paid 476.841,569.441,509.84-969.22
period Length 12.0012.0012.0012.00
period Type ----
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,936.95+61.35(3.27%)
12,803.60-2.55 (-0.02%)